Aktis Oncology Expands Leadership Team with Two Strategic Hires
/PRNewswire/ -- Aktis Oncology, a biotechnology company discovering and developing a novel class of targeted alpha radiopharmaceuticals to treat a broad range...
Stay updated with breaking news from Protein Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Aktis Oncology, a biotechnology company discovering and developing a novel class of targeted alpha radiopharmaceuticals to treat a broad range...
Companies will work toward accessing a novel strategy for breaking the tumor microenvironment by combining ITM’s high-quality radioisotopes with Navigo’s precise target-specific affinity ligands against the fibroblast activation protein (FAP)GARCHING/MUNICH, Germany and HALLE/SAALE, Germany, December 02,...
Dublin, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The "Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd...
Proteins are the molecular machines of all living cells and have been exploited for use in many applications, including therapeutics and industrial catalysts.
Researchers in the United States and China have developed plasmid DNA immunogens that induce effective antibody responses in mice against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).